• Теги
    • избранные теги
    • Компании1348
      • Показать ещё
      • Показать ещё
      Страны / Регионы288
      • Показать ещё
      • Показать ещё
      Международные организации18
      • Показать ещё
      • Показать ещё
      • Показать ещё
Выбор редакции
09 декабря, 00:19

5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices

For those who thought that the pharma/biotech sector is in for an extraordinary run after Donald Trump's unexpected victory, his latest vow to crack down on excessive drug price hikes comes as a bolt from the blue.

08 декабря, 18:08

Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK

Pfizer (PFE) fined for hiking price of an anti-epilepsy drug by up to 2,600% by the Competition and Markets Authority of the UK.

08 декабря, 17:00

Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs

Mylan (MYL) has revealed restructuring programs in certain locations in an attempt to streamline its operations globally as it focuses on integrating acquisitions.

08 декабря, 16:12

Should Biotech Investors Worry About Donald Trump?

It looks like biotech investors may have heaved a sigh of relief a bit too early when Presidential election results were announced last month.

07 декабря, 21:40

Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower

Shares of the iShares Nasdaq Biotechnology ETF (IBB) are down more than 3.6% in morning trading Wednesday following a new warning from President-elect Donald Trump that he will indeed be targeting high drug prices.

Выбор редакции
06 декабря, 21:39

Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today

Shares of Teva Pharmaceutical Industries (TEVA) slipped over 5.8% in morning trading Tuesday after the company announced a change in upper-level management.

Выбор редакции
05 декабря, 18:24

Moving Mylan Forward

Mylan’s price increases for EpiPen created a public firestorm. After becoming a household name for all the wrong reasons, what will the company do next?

Выбор редакции
01 декабря, 20:58

Moving Mylan Forward

How does the company move forward after its price increases for the lifesaving EpiPen? Forbes' Matthew Herper sits down Mylan's Heather Bresch.

Выбор редакции
01 декабря, 19:59

Mylan CEO Bresch Admits 'Full Responsibility' for EpiPen Price Hikes

Mylan CEO Heather Bresch arrived at the 2016 Forbes Healthcare Summit on December 1 surrounded by a cloud of fresh controversy, this one created by her mere appearance at the event. Bresch had refused to testify at a Congressional hearing the day before, where Senator Chuck Grassley (R-Iowa) had planned [...]

Выбор редакции
01 декабря, 19:47

Mylan CEO Hopes EpiPen Furor Leads To 'Price Transparency'

The CEO of Mylan, the maker of the life-saving EpiPen device said she hopes the pricing controversy over the life-saving device for allergy sufferers leads to changes in how drugs are priced in the U.S.

Выбор редакции
Выбор редакции
Выбор редакции
21 ноября, 23:10

Mylan declines Senate committee request to testify about EpiPen

(Reuters) - Mylan NV has declined a U.S. Senate committee request to testify about a $465 million pending settlement to resolve charges the company underpaid government healthcare programs by misclassifying its the EpiPen emergency allergy treatment.

18 ноября, 14:22

Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

This week, companies like Roche (RHHBY) presented data at the annual meeting of the American College of Rheumatology (ACR).

16 ноября, 17:43

6 Things You Need to Know about Teva's (TEVA) Q3 Earnings

Here is a look at key takeaways from Teva's (TEVA) third quarter conference call.

15 ноября, 00:32

Trump's attack dog on climate

Myron Ebell dismisses the science on global warming, mocks environmentalists and has made a career of attacking Republicans for being too soft. And he could soon be leading the EPA.

14 ноября, 18:57

5 Reasons to Buy 5 Low P/E Biotech ETFs

Trump's victory and compelling valuation along with several other factors opened doors for these biotech ETFs.

11 ноября, 16:55

Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?

Pharma stocks surged on Trump's win with companies like Pfizer (PFE) shooting up more than 12% over the last few days.